Outlook for Mantle Cell Lymphoma Therapeutics Market: Key Developments and Future Strategies to 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Much Is the Global Mantle Cell Lymphoma Therapeutics Market Valued at Present and by 2029?
In recent years, there has been a notable increase in the dimensions of the mantle cell lymphoma therapeutics market. The size is projected to increase from $2.42 billion in 2024 to $2.6 billion in 2025, incorporating a compound annual growth rate (CAGR) of 7.1%. The growth observed during the earlier period can be attributed to factors such as advancement in research work, the success of clinical trials, enhancements in diagnostic tools, expansion of treatment access, and collaborative research initiatives.
The market size for therapeutics in mantle cell lymphoma is predicted to experience significant expansion in the coming years. By 2029, the market is projected to reach “$3.5 billion, with a compound annual growth rate (CAGR) of 7.7%. This projected growth during the forecast period can be credited to advancements in targeted therapies, breakthroughs in immunotherapy, the evolution of personalized medicine, market growth on a global scale, and a rise in incidence rates. The main trends for the forecasted period encompass progress in immunotherapy, precision medicine and biomarker creation, pathway-specific targeted therapies, multipronged treatment approaches, and the incorporation of artificial intelligence (AI).
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10813&type=smp
#What Drivers Are Influencing Growth In The Mantle Cell Lymphoma Therapeutics Market?
The mounting occurrence of mantle cell lymphoma is predicted to surge the expansion of the mantle cell lymphoma therapeutics market. Mantle cell lymphoma (MCL) is a distinct type of non-Hodgkin lymphoma (NHL) that affects the lymphatic system. Therapies for mantle cell lymphoma contribute towards reducing its severity by managing and treating the disorder and enhancing patients’ results, extending survival, and diminishing the disease’s load. For example, the National Library of Medicine, an American-based biomedical library run by the United States Federal Government, stated in December 2022 that the annual incidence of mantle cell lymphoma is one in 200,000 people, accounting for 5% of all non-Hodgkin’s lymphomas. Consequently, the escalating occurrence of mantle cell lymphoma is promoting the mantle cell lymphoma therapeutics market’s progress.
The mantle cell lymphoma therapeutics market covered in this report is segmented –
1) By Type: Combination Therapy, Monotherapy
2) By Mechanism of Action: Bruton Tyrosine Kinase Inhibitors, Alkylating Agents, Deoxyribonucleic Acid Synthesis Inhibitors, Microtubule Inhibitors, Monoclonal Antibodies, Other Mechanisms
3) By Route of Administration: Oral, Parenteral
4) By Application: Hospital, Research Institute, Other Applications
Subsegments:
1) By Combination Therapy: Chemotherapy Combinations, Targeted Therapy Combinations, Immunotherapy Combinations
2) By Monotherapy: Single-Agent Chemotherapy, Targeted Therapy Monotherapy, Immunotherapy Monotherapy
What Are The Leading Trends And Opportunities In The Mantle Cell Lymphoma Therapeutics Sector?
A key trend emerging in the mantle cell lymphoma therapeutics market is the evolution of targeted therapy drugs. Top companies in this market are progressing towards developing new targeted therapy drugs to maintain their market standing. For example, in March 2023, AstraZeneca plc, a pharmaceutical company based in the UK, secured approval from the National Medical Products Administration (NMPA) to sell their drug, Calquence (acalabrutinib), in China. This drug, aimed towards adult patients with mantle cell lymphoma (MCL), is a selective Bruton’s tyrosine kinase (BTK) inhibitor and provides a new, manageable, and effective treatment alternative for mantle cell lymphoma.
Which Companies Play A Key Role In The Development Of The Mantle Cell Lymphoma Therapeutics Market?
Major companies operating in the mantle cell lymphoma therapeutics market include AstraZeneca plc, Celgene Corporation, Johnson & Johnson Consumer Inc., Takeda Pharmaceutical Company Limited, Bayer Aktiengesellschaft, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Kite Pharma Inc., Gilead Sciences Inc., AbbVie Inc., Bristol-Myers Squibb Company, Novartis AG, Merck & Co. Inc., Massive Bio Inc., Juno Therapeutics Inc., Nurix Therapeutics Inc., Janssen Biotech Inc., TG Therapeutics Inc., F. Hoffmann-La Roche AG, Astex Pharmaceuticals Inc., Astellas Pharma Inc., BeiGene Ltd., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Exelixis Inc., Hutchison China MediTech Limited, Incyte Corporation, Ionis Pharmaceuticals Inc.
What Are The Key Regional Developments Shaping The Mantle Cell Lymphoma Therapeutics Market?
North America was the largest region in the global mantle cell lymphoma therapeutics market in 2024. The regions covered in the mantle cell lymphoma therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=10813&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
